UK MHRA

OXFORD: Sensyne Health plc, the British clinical AI technology company, announced it has entered into a formal research agreement with the UK MHRA (Medicines and Healthcare products Regulatory Agency) to contribute to the development of methods to validate software algorithms used in digital health. Lord (Paul) Drayson, CEO of Sensyne Health, said: “New techniques using…